Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834034/ https://www.ncbi.nlm.nih.gov/pubmed/28407031 http://dx.doi.org/10.1093/annonc/mdx170 |
_version_ | 1783303583411732480 |
---|---|
author | Chin, K. Chand, V. K. Nuyten, D. S. A. |
author_facet | Chin, K. Chand, V. K. Nuyten, D. S. A. |
author_sort | Chin, K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5834034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58340342018-03-07 Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy Chin, K. Chand, V. K. Nuyten, D. S. A. Ann Oncol Industry Corner: Perspectives and Controversies Oxford University Press 2017-07 2017-04-12 /pmc/articles/PMC5834034/ /pubmed/28407031 http://dx.doi.org/10.1093/annonc/mdx170 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Industry Corner: Perspectives and Controversies Chin, K. Chand, V. K. Nuyten, D. S. A. Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
title | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
title_full | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
title_fullStr | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
title_full_unstemmed | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
title_short | Avelumab: clinical trial innovation and collaboration to advance anti-PD-L1 immunotherapy |
title_sort | avelumab: clinical trial innovation and collaboration to advance anti-pd-l1 immunotherapy |
topic | Industry Corner: Perspectives and Controversies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834034/ https://www.ncbi.nlm.nih.gov/pubmed/28407031 http://dx.doi.org/10.1093/annonc/mdx170 |
work_keys_str_mv | AT chink avelumabclinicaltrialinnovationandcollaborationtoadvanceantipdl1immunotherapy AT chandvk avelumabclinicaltrialinnovationandcollaborationtoadvanceantipdl1immunotherapy AT nuytendsa avelumabclinicaltrialinnovationandcollaborationtoadvanceantipdl1immunotherapy |